期刊文献+

慢性肝脏疾病中CD3^-CD161^+NK和CD3^+CD161^+NKT细胞亚群的变化研究 被引量:5

Alterations of CD3^-CD161^+ NK cell and CD3^+ CD161^+ NKT Cell population in the chronic hepatic diseases
原文传递
导出
摘要 目的探讨CD3^-CD161^+NK、CD3^+CD161^+NKT细胞在慢性肝炎/肝硬化及肝细胞癌患者肝脏组织及外周血中表达及意义。方法利用流式细胞仪对31例肝细胞癌患者、59例慢性肝炎/肝硬化患者肝脏组织及外周血、15例正常肝脏组织、48例正常人外周血中的CD3^-CD161^+NK和CD3^+CD161^+NKT进行定量分析。结果慢性肝炎/肝硬化组CD3^-CD161^+NK细胞[(13.4±1.3)%]和肝细胞癌癌周组CD3^-CD161^+NK细胞[(16.7±4.8)%]及远离肝癌组的肝脏组织CD3^-CD161^+NK细胞[(22.0±4.4)%]与正常肝脏组织CD3^+CD161^+NK细胞[(35.1±7.2)%]相比,肝细胞癌癌周肝脏组织内含量最低(t值分别为2.301、2.137、2.034,P〈0.05);外周血中肝细胞癌组CD3^-CD161^+NK细胞f(11.6±6.3%)]、CD3^+CD161^+NKT细胞[(14.7±6.2)%]与慢性肝炎/肝硬化组CD3^-CD161^+NK细胞[(10.8±1.7)%]、CD3^+CD161^+NKT细胞[(12.5±0.8)%]、正常对照组CD3^+CD161^+NK细胞[(7.5±0.8)%]、CD3^-CD161^+NKT细胞[(13.8±1.7)%]相比肝癌组CD3^-CD161^+NKT细胞含量最高(t值分别为2.134,2.099,P〈0.05),肝癌组CD3^+CD161^+NKT细胞含量最高(t值分别为2.125,2.154,P〈0.05)。结论由于NK细胞及NKT细胞数量减少或/和活性降低,使肿瘤细胞逃逸了免疫监视,可能促进了肿瘤的发生、发展及转移。 Objective To investigate the significance of the alteration of NK cell population in hepatocellular carcinoma (HCC). Methods The number and distribution of CD3^-CD161^+ NK cells, CD3^+ CD161^+ NKT cells in liver tissue (31 patients vs 15 healthy controls) and peripheral blood (59 patients vs 48 healthy controls) of chronic hepatitis/hepatic cirrhosis were analyzed by flow cytometry. Results CD3^-CD161^+ NK cells[ (16.7 ± 4.8 )% ] , in the surrounding tissue of HCC were significantly lower than far distancing hepatocellular carcinoma group[ ( 22.0 ±4.4 ) % ], chronic hepatitis/hepatic cirhosis group [ ( 13.4 ±1.3 ) % ], and normal control group[ (35. 1 ±7.2 ) % ] (t = 2. 301,2. 137,2. 034, P 〈 0.05 ). CD3^-CD161 ^+ NK cells [ ( 11.6 ±6.3 )% ] and CD3^+ CD161^ + NKT cells [ ( 14.7 ±6.2 )% ] in peripheral blood of HCC were significantly higher than ehronic hepatitis/hepatic cirrhosis [ ( 10.8 ± 1.7 ) % , ( 12.5 ± 0.8 ) % ] and normal control group [(7.5±0.8)%,(13.8±1.7)%],(t=2.134,2.099,P〈0.05). Conclusion The number of NK cells and NKT cells in the surrounding tissue of HCC was decreased. This result may imply that tumor may escape from immunological surveillance mechanisms, leading to its advanced stages.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第2期163-164,F0003,共3页 International Journal of Immunology
基金 黑龙江省留学归国及海外学者合作基金项目(LC06C30) 黑龙江省教育厅科学技术研究面上项目(11531191)
关键词 CD3^-CD161^+NK细胞 CD3^-CD161^+NKT细胞 肝细胞癌 CD3^-CD161^+ NK cell CD3^+CD161^+NKT cell Hepatocellular carcinoma
  • 相关文献

参考文献11

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14017
  • 2Eberl G,Lees R,Smiley ST,et al.Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells.J Immunol,1999,162(11):6410-6419.
  • 3王敏,王福生.NK细胞和NKT细胞在病毒性肝炎中的作用[J].免疫学杂志,2003,19(S1):138-141. 被引量:10
  • 4Godfrey DI,Hammnond KJ,Pouhon LD,et al.NKT cells:facts,functions and fallacies.Immunol Today,2000,21(11):573-583.
  • 5Kawarabayashi N,Seki S,Hatsuse K,et al.Decrease of CD56^+ T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.Hepatology,2000,32(5):962-969.
  • 6菅原 聡,市田隆文,佐藤万成他:肝疾患ぐゎける胸腺外分化 T リンパ、球の役割.肝胆膵,1999,38(3):461-468.
  • 7石彦,余佩武,雷晓,曾冬竹,宋爽,周立新.胃癌患者外周血淋巴细胞免疫功能的研究[J].重庆医学,2004,33(2):229-231. 被引量:16
  • 8Garzetti GG,Gavattini A,Goteri G,et al.natural killer cell activity in patients with invasive cervical carcinoma:imporatance of a longitudinal evaluation in follow-up.Aaaagyneeol Obstet Invest,1995,40(2):133-138.
  • 9何畏,叶之美,卞度宏.卵巢癌患者全身及肿瘤局部细胞免疫功能的测定[J].重庆医科大学学报,1997,22(1):34-36. 被引量:2
  • 10中島 猛行,金井 弘一:肝硬变かん肝癌の凳生、免疫能低下と凳癌、NK细胞ち中心ぐ.Medical Practice,1985,2(4):1956-1600.

二级参考文献15

  • 1李俊 李峰 吴克宁 等.恶性肿瘤患者细胞免疫功能的变化[J].中国肿瘤临床与康复,1998,4:22-22.
  • 2Kawarabayashi N,Seki S,Hatsuse K,et al.Decrease of CD56 (+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.Hepatology,2000,32:962-969.
  • 3Deignan T,Curry MP,Doherty DG,et al.Decrease in hepatic CD56(+)T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection.J Hepatol,2002,37:101-108.
  • 4Sarobe P,Lasarte JJ,Zabaleta A,et al.Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.J Virol,2003,77:10862-10871.
  • 5Auffermann-Gretzinger S,Keeffe EB,Levy S.Impaired dendritic cell maturation in patients with chronic,but not resolved,hepatitis C virus infection.Blood,2001,97:3171-3176.
  • 6Lau JY,Tam RC,Liang TJ,et al.Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.Hepatology,2002,35:1002-1009.
  • 7田志刚,孙汭.NK细胞的免疫学调节功能[J].国外医学(肿瘤学分册),1997,24(3):136-138. 被引量:23
  • 8朱金水,蒋西华,徐家裕,王冠庭,马宝骊.人胃癌细胞产生免疫抑制因子作用研究[J].中国免疫学杂志,1998,14(3):201-203. 被引量:7
  • 9张小化,唐兰,凌瑞,刘侠.进展期胃癌手术前、后免疫功能变化[J].中国肿瘤临床,1998,25(8):611-611. 被引量:1
  • 10彭贵勇,蔡景修,袁爱力.肝癌患者免疫功能变化及其影响因素[J].重庆医学,1999,28(6):421-422. 被引量:6

共引文献14040

同被引文献93

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部